Hospital Pharmacy Operations Report (HPOR) 2023-24
Hospital Pharmacy Operations Report (HPOR) 2023-24
The 10th annual Hospital Pharmacy Operations Report (HPOR) presents a detailed examination of the prevailing…
Panel: Measuring the Effectiveness of Your Drug Diversion Program
For this panel, four leaders in drug diversion prevention came together to discuss the key…
Diversion Collective Overview
The Diversion Collective is a virtual learning cohort facilitated through the Bluesight Community. Our program enriches…
Diversion Quarterly Q4, 2023
Bluesight is sharing data from its ControlCheck platform on a quarterly basis to provide insight…
Diversion Quarterly Q3, 2023
Bluesight® is sharing data from its ControlCheck platform on a quarterly basis to provide insight…
DEA Compliance Discussion with Susannah Herkert
Susannah, with her extensive experience both as a Senior Managing Director at Guidepost Solutions and…
Drug Enforcement Series Part 3: Tackling Pharmaceutical Drug Diversion Directly
As part of our Drug Enforcement Series. Lorri Hall, President of DETECT RX CONSULTING INC….
A Prescription for Safety: Technology is Imperative to Detect and Prevent Drug Diversion
The first ‘Sentara Promise’ we make to patients is to Always Keep You Safe. For…
Recording: Diversion Enforcement- A DEA Investigator’s Perspective
Is my hospital prepared for a potential Drug Administration Enforcement audit? What are DEA investigators…
Diversion Quarterly, Q2 2023
The diversion market is consolidating and Bluesight is excited to welcome Medacist customers to our…